Brief: Chimeric Therapeutics Enters A$30 Million Equity Placement Agreement With L1 Capital
09/06/2022 02:41
June 9 (Reuters) - Chimeric Therapeutics Ltd CHM.AX :
* ENTERS A$30 MILLION EQUITY PLACEMENT AGREEMENT WITH L1
CAPITAL
* PLACEMENT AGREEMENT COMPRISES INITIAL PLACEMENT OF
A$500,000 IN
ORDINARY SHARES AT A$0.10 PER SHARE
Source text for Eikon: ID:nASX3nfjTB
Further company coverage: CHM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial